High Point Advisor Group LLC Astrazeneca PLC Transaction History

High Point Advisor Group LLC

$1.75 Billion
Q4 2024

A detailed history of High Point Advisor Group LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, High Point Advisor Group LLC holds 22,180 shares of AZN stock, worth $1.73 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares

22,180

Previous 22,368 0.84%

Holding current value

$1.73 Million

Previous $1.74 Million 16.59%

% of portfolio

0.08%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	SELL	$63.2 - $79.58 $11,881 - $14,961	-188 Reduced 0.84%	22,180 $1.45 Million
Q3 2024 Nov 04, 2024	SELL	$76.67 - $87.62 $102,967 - $117,673	-1,343 Reduced 5.66%	22,368 $1.74 Million
Q2 2024 Aug 08, 2024	SELL	$66.81 - $80.83 $278,130 - $336,495	-4,163 Reduced 14.94%	23,711 $1.85 Million
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $447,838 - $510,504	7,338 Added 35.73%	27,874 $1.89 Million
Q4 2023 Mar 26, 2024	BUY	$61.89 - $69.28 $370,782 - $415,056	5,991 Added 41.19%	20,536 $1.38 Million
Q2 2022 Aug 15, 2022	SELL	$59.26 - $71.14 $178,017 - $213,704	-3,004 Reduced 17.12%	14,545 $967,000
Q3 2021 Nov 15, 2021	BUY	$55.56 - $60.79 $27,279 - $29,847	491 Added 2.88%	17,549 $1.05 Million
Q2 2021 Jul 29, 2021	BUY	$48.42 - $60.18 $130,249 - $161,884	2,690 Added 18.72%	17,058 $1.02 Million
Q1 2021 Apr 12, 2021	BUY	$47.16 - $54.44 $12,450 - $14,372	264 Added 1.87%	14,368 $718,000
Q4 2020 Feb 10, 2021	BUY	$48.52 - $58.02 $195,293 - $233,530	4,025 Added 39.93%	14,104 $711,000
Q3 2020 Nov 06, 2020	BUY	$53.07 - $61.1 $274,318 - $315,825	5,169 Added 105.27%	10,079 $556,000
Q2 2020 Aug 13, 2020	SELL	$43.1 - $55.31 $1,293 - $1,659	-30 Reduced 0.61%	4,910 $262,000
Q1 2020 May 01, 2020	BUY	$37.79 - $51.33 $177,159 - $240,635	4,688 Added 1860.32%	4,940 $252,000
Q1 2020 Apr 27, 2020	SELL	$37.79 - $51.33 $183,772 - $249,617	-4,863 Reduced 95.07%	252 $4.94 Million
Q4 2019 Feb 13, 2020	SELL	$42.46 - $50.46 $19,234 - $22,858	-453 Reduced 8.14%	5,115 $259,000
Q3 2019 Nov 12, 2019	BUY	$40.12 - $45.47 $3,851 - $4,365	96 Added 1.75%	5,568 $263,000
Q2 2019 Aug 15, 2019	BUY	$37.28 - $41.68 $1,975 - $2,209	53 Added 0.98%	5,472 $220,000
Q1 2019 May 08, 2019	SELL	$35.49 - $43.02 $7,133 - $8,647	-201 Reduced 3.58%	5,419 $205,000
Q4 2018 Feb 20, 2019	SELL	$36.86 - $41.49 $58,976 - $66,384	-1,600 Reduced 22.16%	5,620 $227,000
Q3 2018 Oct 24, 2018	SELL	$34.76 - $39.72 $26,209 - $29,948	-754 Reduced 9.46%	7,220 $285,000
Q2 2018 Aug 20, 2018	SELL	$34.55 - $37.05 $44,604 - $47,831	-1,291 Reduced 13.93%	7,974 $303,000
Q1 2018 Jun 11, 2018	SELL	$32.97 - $36.63 $42,366 - $47,069	-1,285 Reduced 12.18%	9,265 $337,000
Q4 2017 Feb 15, 2018	BUY	$32.09 - $34.78 $7,348 - $7,964	229 Added 2.22%	10,550 $359,000
Q3 2017 Nov 06, 2017	BUY	$28.96 - $34.0 $298,896 - $350,914	10,321	10,321 $352,000

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Account

High Point Advisor Group LLC Astrazeneca PLC Transaction History